Mrs Florence Petit Dop
International Research Institute Servier (IRIS), Suresnes (France)
Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects
Event: ESC Congress 2020
Topic: Clinical
Session: Advances in Chronic Thromboembolic Pulmonary Hypertension
ESC 365 is supported by
